metricas
covid
Buscar en
Revista Española de Cirugía Ortopédica y Traumatología
Toda la web
Inicio Revista Española de Cirugía Ortopédica y Traumatología Clinical–epidemiological profile of the patient attended in a Fracture Liaison...
Información de la revista
Vol. 67. Núm. 3.
Páginas 210-215 (mayo - junio 2023)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Visitas
781
Vol. 67. Núm. 3.
Páginas 210-215 (mayo - junio 2023)
Original article
Acceso a texto completo
Clinical–epidemiological profile of the patient attended in a Fracture Liaison Service (FLS) of a regional hospital in north-west of Spain
Perfil clínico-epidemiológico del paciente atendido en una unidad multidisciplinar de fractura de cadera de un hospital de primer nivel en el noroeste de España
Visitas
781
A. Marchán-Lópeza, B.A. Castro-Condea, J. Cambón-Cotelob, V. Quevedo-Vilac, J. López-Castro Ja,
Autor para correspondencia
jlcastro126@hotmail.com

Corresponding author.
, on behalf of FLS-HPM Team
a Internal Medicine Department, Hospital Público de Monforte, Lugo, Spain
b Traumatology Department, Hospital Público de Monforte, Lugo, Spain
c Reumatology, Internal Medicine Department, Hospital Público de Monforte, Lugo, Spain
Contenido relacionado
A. Marchán-López, B.A. Castro-Conde, J. Cambón-Cotelo, V. Quevedo-Vila, J. López-Castro
Este artículo ha recibido
Información del artículo
Resumen
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Figuras (1)
Tablas (2)
Table 1. Baseline characteristics of patients hospitalized for hip fracture (n=101).
Table 2. Postoperative and post-discharge evolution (n=101).
Mostrar másMostrar menos
Abstract
Introduction

Hip fractures constitute a capital public health issue associated with aging and frailty because of its impact on both quality of life and morbidity and mortality in older people. Fracture Liaison Services (FLS) have been proposed as tools to minimize this emergent problem.

Material and methods

A prospective observational study was conducted with 101 patients treated for hip fracture by the FLS of a regional hospital between October 2019 and June 2021 (20 months). Epidemiological, clinical, surgical and management variables were collected during admission and up to 30 days after discharge.

Results

Mean age of patients was 87.6±6.1 years and 77.2% were female. Some degree of cognitive impairment was detected at admission in 71.3% of patients using the Pfeiffer questionnaire, and 13.9% were nursing home residents, and 76.24% could walk independently before the fracture. Fractures were more commonly pertrochanteric (45.5%). Patients were receiving antiosteoporotic therapy in 10.9% of cases. The median surgical delay from admission was 26h (RIC 15–46h), the median length of stay was 6 days (RIC 3–9 days) and in-hospital mortality was 10.9%, and 19.8% at 30 days, with a readmission rate of 5%.

Discussion

Patients treated in our FLS at the beginning of its activity were similar to the general picture in our country in terms of age, sex, type of fracture, and proportion of patients treated surgically. A high mortality rate was observed, and low rates of pharmacological secondary prevention were followed at discharge. Clinical results of FLS implementation in regional hospitals should be assessed prospectively in order to decide their suitability.

Keywords:
Hip fracture
Multidisciplinary unit
FLS
Morbidity
Mortality
Resumen
Introducción

Las fracturas de cadera constituyen un problema de salud pública capital asociado al envejecimiento y la fragilidad por su impacto en la calidad de vida y la morbimortalidad de las personas mayores. Se ha propuesto el uso de servicios de enlace de fracturas (FLS) para minimizar este problema emergente.

Material y métodos

Estudio observacional prospectivo con 101 pacientes con fractura de cadera tratados en el FLS de un hospital regional entre octubre de 2019 y junio de 2021 (20 meses). Se recogieron variables epidemiológicas, clínicas y quirúrgicas durante el ingreso y hasta 30 días después del alta.

Resultados

La edad media de los pacientes fue de 87,6±6,1 años, el 77,2% eran mujeres y el 71,3% tenían deterioro cognitivo al ingreso según el cuestionario de Pfeiffer. El 13,9% estaban institucionalizados y el 76,24% podían caminar de forma independiente antes de la fractura. Las fracturas fueron más frecuentemente pertrocantéricas (45,5%). Los pacientes recibían tratamiento antiosteoporótico en el 10,9% de los casos. La mediana de la demora quirúrgica desde el ingreso fue de 26 horas (RIC 15-46 horas), la mediana de la estancia fue de 6 días (RIC 3-9 días) y la mortalidad intrahospitalaria fue del 10,9%, y del 19,8% a los 30 días, con una tasa de reingreso del 5%.

Discusión

Los pacientes tratados en nuestro FLS al inicio de su actividad eran similares a la imagen general de nuestro país en cuanto a edad, sexo, tipo de fractura y proporción de pacientes tratados quirúrgicamente. Se observó una alta tasa de mortalidad y se siguieron bajas tasas de osteoprotección al alta. Los resultados clínicos de la implantación del FLS en los hospitales regionales deben ser evaluados de forma prospectiva para decidir su idoneidad.

Palabras clave:
Fractura de cadera
Unidad multidisciplinar
FLS
Morbilidad
Mortalidad
Texto completo
Introduction

Hip fractures (HF) are one of the main health problems associated with aging and frailty because of its impact on both quality of life and morbimortality in the elderly, being an independent risk factor for mortality.1 Its estimated overall incidence in Spain is 104 cases per 100,000 inhabitants, which means some 45,000–50,000 hip fractures per year with an annual cost of 1591 million euros.2 It is predominantly found in elderly patients; 85.4% of all HF occur in those over 75 years of age and 2/3 in those over 80 years of age,3 and incidence surges to between 301 and 897 fractures per 100,000 people of 65 years or older.4 Women are three times more likely than men to suffer HF under 80 years, although the difference diminishes with increasing age due to senile osteoporosis.5,6 In Spain, 4.3% of patients die during the admission for HF, and 30% die during the first year after the fracture, while 50–60% of survivors do not recover their functional status.7,8

The underlying factor in most HF is osteoporosis, a decrease in bone density which leads to lower bone resistance to trauma, at the same time increasing the risk of instability and mechanical failure after surgery.7 HF patients have high rates of multi-morbidity, cognitive or functional impairment, nutritional issues, etc.,9–13 and medical complications are frequent in the postoperative period. Medical–surgical treatment is associated with fewer complications and mortality.14

In recent years Fracture Liaison Services (FLS) have been proposed to address the emerging public health issue which HF constitute. FLS are coordinator-based, multidisciplinary care units whose aims are to identify all patients with HF and ensure they receive the optimal inpatient therapy and secondary fracture prevention.15 These units have demonstrated their efficacy, reducing the occurrence of new fractures by 30–40% in a cost-effective manner for health systems.16 In Spain, FLS are being implemented as a means for reducing the impact HF have on the National Health Service, with coordination from the National Hip Fracture Registry (RNFC), which collects data from HF patients older than 75 years. In our Regional Hospital, an FLS was implemented in the second half of 2019. This study aims to describe the characteristics and outcomes of HF patients treated in our FLS, and explore which factors are related with death, readmission and length of stay in this population.

Material and methods

A prospective observational study was carried out, recruiting all patients over 75 years of age admitted for hip fracture in a first level care hospital with 141 beds between October 2019 and June 2021 (20 months). Patients admitted for this reason to the Traumatology ward who agreed to participate were included, after informed consent had been signed by them or their relatives in the case of patients with dementia. The only exclusion criterion was declining to participate. The data record came from the RNFC database to which our hospital center is attached and whose collection protocol was approved by the Research Ethics Committee with promoter code 2016_89 (RNFC). The investigators conducted the study in accordance with the principles of the Declaration of Helsinki and the Oviedo Convention. The study was developed in accordance with the protocol and in compliance with the standards of good clinical practice, as described in the International Conference on Harmonization standards for good clinical practice.

Epidemiological, clinical, surgical and management variables were collected during admission and 30 days after discharge. Fractures were classified from a prognostic and therapeutic point of view, distinguishing between intracapsular (biological problem, treated by arthroplasty or osteosynthesis with cannulated screws) and extracapsular (mechanical problem, treated with endomedullary nailing or sliding screw system). Statistical analysis was performed using R (R Core Team, Vienna, Austria, 2019) and RStudio (RStudio, Boston, MA, 2019). Categorical variables were expressed as absolute and relative frequency. Quantitative variables were expressed as mean and standard deviation, or median and interquartile range (IQR) in case of presenting a non-Gaussian distribution. Factors related to death, readmission, surgical delay and hospital stay were studied using uni- and multivariable logistic and linear regression analyses, respectively. The relationship of these factors with the results was expressed in terms of odds ratio (OR) and 95% confidence interval, or coefficients in the case of linear regression.

Results

During the 20 months of the study, 101 patients with HF were admitted to our center (Table 1). The mean age was 87.6±6.1 years, with a clear predominance of women (77.2%). Some 13.9% were institutionalized before the fracture and 71.3% of the patients had some degree of cognitive impairment, as measured by the Pfeiffer questionnaire, yet 76.24% were independent for ambulation.

Table 1.

Baseline characteristics of patients hospitalized for hip fracture (n=101).

Variable  N(%); Me(RIC); M±DE 
Sex, female  78 (77.2) 
Age (years)  87.6±6.1 
Institutionalized  14 (13.9) 
Mobility before fracture
Fully independent  27 (26.7) 
Independent with cane  10 (9.9) 
Independent with walker  6 (5.9) 
Independent at home  7 (6.9) 
Home with cane  11 (10.9) 
Home with walker  8 (7.9) 
Home with supervision  7 (6.9) 
Home with 1 person assistance  9 (8.9) 
Home with major assistance  6 (5.9) 
Bedridden  9 (8.9) 
Pfeiffer (errors) (n=75)  5 (0–10) 
Pfeiffer (category) (n=75)
Cognitively intact (0–3)  30 (29.7) 
Mild cognitive impairment (4–5)  11 (10.9) 
Moderate impairment (6–8)  14 (13.9) 
Severe impairment (9–10)  20 (19.8) 
Previous antiosteoporotic treatment  11 (10.9) 
Previous calcium supplementation  17 (16.8) 
Previous Vitamin D  37 (36.6) 
Fracture type
Intracapsular non displaced  10 (9.9) 
Intracapsular displaced  35 (34.6) 
Pertrochanteric  46 (45.5) 
Subtrunkanteric  7 (6.9) 
Others  3 (2.9) 
Fracture side, left  41 (40.6) 
Pathologic fracture  1 (1.0) 
Pre-surgical mortality  1 (1.0) 
Operated  100 (99.0) 
Type of intervention (n=100)
Intramedullary nail  41 (41) 
Cemented hemiarthroplasty  24 (24) 
Sliding screw  12 (12) 
Cannulated screws  9 (9) 
Uncemented hemiarthroplasty  8 (8) 
Cemented PTC  3 (3.0) 
Others  3 (3.0) 

n: sample size; N: absolute frequency; Me: median; IQR: interquartile range; M: mean; SD: standard deviation.

The most frequent type of fracture was pertrochanteric (46 cases, 45.5% of the total), followed by displaced intracapsular (34.6%), non-displaced intracapsular (9.9%), subtrochanteric (6.9%) and only 3 patients (3.0%) had atypical fractures. Only 10.9% of the patients were receiving antiosteoporotic therapies (resorption inhibitors and/or bone anabolics) at the time of the hip fracture. Of the 101 patients with fractures, 100 (99.0%) underwent surgery; only one patient did not undergo fracture repair because she died before surgery. The median surgical delay from admission (Fig. 1) was 26h (RIC 15–46h), with 79.0% of patients undergoing surgery within the guideline target of 48h from admission14,16,17 and all of them undergoing surgery under neuroaxial anesthesia. Eighty-seven percent of the patients were seated on the first postoperative day and the median stay was 6 days (RIC 3–9 days). Only 36.6% of patients benefited from comprehensive evaluation by Geriatrics or Internal Medicine and in-hospital mortality was 10.9%. At 30-day follow-up, mortality was 19.8%, while the readmission rate was 5% (2% due to surgery-related causes and 3% to medical causes). Regarding osteoporosis treatment, 27.8% of the patients were discharged with pharmacological secondary prevention treatment, while 33.8% of the patients who were still alive at 30 days were receiving it (Table 2).

Figure 1.

Surgical delay time in the 100 patients operated on for hip fracture.

(0.08MB).
Table 2.

Postoperative and post-discharge evolution (n=101).

Variable  N(%); Me(RIC); M±DE 
Sitting POD1 (n=100)  87 (87) 
Interconsultation with other physicians  37 (36.6) 
Discharge destination
Exitus  11 (10.9) 
Home address  70 (69.3) 
Nursing home  20 (19.8) 
Stay (days)  5.7 (2.5–8.5) 
Osteoprotection at discharge (n=90)  25 (27.8) 
Calcium at discharge (n=90)  28 (31.1) 
Vitamin D at discharge (n=90)  34 (37.8) 
Status at 30 days (n=90)
Cumulative mortality (n=100)  20 (19.8) 
Related readmission  5 (5.5) 
Re-operation  2 (2.2) 
Institutionalized (n=80)  18 (22.5) 
Antiosteoporotic treatment (n=80)  27 (33.8) 
Vitamin D (n=80)  80 (100) 

n: sample size; N: absolute frequency; Me: median; IQR: interquartile range; M: mean; SD: standard deviation; POD1: first postoperative day.

None of the variables studied (sex, age, previous mobility, cognitive impairment, previous institutionalization, ASA surgical risk category, type of fracture, surgical delay) was significantly associated with in-hospital mortality or readmission. Regarding hospital stay, multivariate analysis found that institutionalized patients had significantly shorter stays (−2.3 days mean stay, 95%CI −1.2 to −3.6 days). Finally, no greater surgical delay was observed according to any of the aforementioned variables.

Discussion

Even in COVID-19 times, hip fractures continue to be an important cause of morbidity and mortality among older patients worldwide.18 It entails a high healthcare cost for health systems, both direct and indirect, as well as a significant decrease in health-related quality of life.19 In Europe, the incidence of fragility hip fracture is increasing mainly due to increased life expectancy.20 Patients who have a hip fracture are 86% more likely to experience a second fracture, generally in the first year after the index fracture,21 and 50% of all hip fractures occur in the 16% of the population who have already had a fracture previously. In spite of this, and inexplicably, less than 10% of patients who have suffered a hip fracture in Europe receive treatment with bisphosphonates. FLS are the most cost-effective model of approach to secondary fracture prevention and a good strategy for bridging this terrible therapeutic gap.22,23

Our sample consists mainly of women, very elderly, living in the community, with a high prevalence of cognitive impairment, but mostly independent before the HF. This is similar to what is reported for the Spanish population except for the unusually high rate of dementia.24 Mortality is also higher than usually reported in the literature,25–27 but at the time of the implementation of our FLS no Orthogeriatrics/Hospitalist comanagement program existed at our institution. Other FLS experiences have also failed to show mid-term benefits in mortality.28 Surgical management of fractures was almost universal, and 79% of patients were operated in the first 48h of admission, this being both a guideline recommendation15 and a marker of quality of care and early intervention being associated with a reduction in hospital stay.8,29

The rate of antiosteoporotic treatment was nonetheless low, with less than a third of patients receiving it at discharge, and only slightly more at 30 days. These rates are lower than observed in the RNFC, although this sample represents the first months of FLS activity, and continuous improvement is expected as the team gathers experience and revises its activity and results.29 In our region, Galicia, only another University Hospital (Clínico Universitario in Santiago de Compostela) and our Regional Hospital have International Osteoporosis Foundation certified FLS within the “Capture the Fracture” program. The degree of satisfaction of patients and professionals in these units is high, generating a collaborative environment conducive to promoting coordinated and prospectively evaluated teamwork.23

For all these reasons, and with all the clinical evidence available on the subject, implementing the FLS model and units with systematic shared care for the joint care of fractured patients from admission should be a priority at the present time, thus shortening hospital stay, reducing complications, minimizing functional deterioration and costs and above all improving mortality in the medium and long term.29

Limitations of the study

We recognize that the study has certain limitations, since it is a single-center study, with a small sample size, carried out by a recently created FLS unit, in a Regional hospital, with a very aged target population and where it was not possible to include all the hip fractures due to reasons derived from the pandemic situation due to COVID-19. Although the sample size and follow-up time may be short, we believe that they are sufficient to establish conclusions, although modest, which are sufficiently solid and which may serve to stimulate other small hospitals to create similar units for the benefit of the patients they serve.

Level of evidence

Level of evidence ii.

Funding

The study was carried out without external funding.

Conflict of interest

The authors declare that they have no conflicts of interest.

Acknowledgments

We would like to thank the entire Traumatology Service of the Hospital Público de Monforte for their excellent willingness to collaborate in the recruitment of patients for our study and Dr. Romina González Vázquez for proofreading the text.

Appendix A
FLS-HPM Team (co-authors)

Rocío Arias Sanmiguel, Pamela Fernández Águila, Laura Ferreira Varela, María González Varela, Alberto Iglesias Seoane, Mónica Jacobo Castro, Alba Lobelle Seijas, Diana Lourido Mondelo, Noelia Rodríguez Sampayo

References
[1]
M. Katsoulis, V. Benetou, T. Karapetyan, D. Feskanich, F. Grodstein, U. Pettersson-Kymmer, et al.
Excess mortality after hip fracture in elderly persons from Europe and the USA: the CHANCES project.
J Intern Med, 281 (2017 Mar), pp. 300-310
[2]
P. Sáez López, J.I. González-Montalvo, C. Ojeda-Thies, P. Gómez-Campelo.
National Registry of hip fractures due to fragility in the elderly (RNFC).
Annu Rep, (2018), pp. 21
[3]
M. De Miguel-Artal, O. Roca-Chacón, M. Martínez-Alonso, M. Serrano-Godoy, J. Mas-Atance, R. García-Gutiérrez.
Hip fracture in the elderly patient: prognostic factors for mortality and functional recovery at one year.
Rev Esp Geriatric Geront, 53 (2018), pp. 247-254
[4]
M. Fernández-García, J. Martínez, J.M. Olmos, J. González-Macías, J.L. Hernández.
Revisión de la incidencia de fractura de cadera en España.
Rev Osteoporos Metab Miner, 7 (2015),
[5]
P. Zamora-Navas, M. Esteban-Peña.
Seasonality in incidence and mortality of his fracture.
Rev Esp Ortop Traumatol, 63 (2019), pp. 132-137
[6]
E. Keener.
Femoral fractures.
Orthopaedic knowledge update 12,
[7]
R. Monte-Secades, P. Codesido-Villar, F.J. Pardo-Sobrino, E.I. García-Monasterio, A. Portero-Vázquez, M. García-Novio, et al.
Clinical route for hospitalized patients with osteoporotic hip fracture.
Galicia Clin, 77 (2016), pp. 57-66
[8]
J. López Castro.
Time is money and time is life.
Pol Arch Intern Med, 130 (2020 Jun 25), pp. 481-482
[9]
Q. Yang, J. Wang, Y. Xu, Y. Chen, Q. Lian, Y. Zhang.
Incidence and risk factors of in-hospital prosthesis-related complications following total hip arthroplasty: a retrospective Nationwide Inpatient Sample database study.
Int Orthop, 44 (2020), pp. 2243-2252
[10]
H.A. Bischoff-Ferrari.
Vitamin D and fracture prevention.
Rheum Dis Clin North Am, 38 (2012), pp. 107-113
[11]
H. Bischoff-Ferrari, H.B. Stähelin, P. Walter.
Vitamin D effects on bone and muscle.
Int J Vitam Nutr Res, 81 (2011), pp. 264-272
[12]
M.K. Karlsson, H. Magnusson, T. von Schewelov, B.E. Rosengren.
Prevention of falls in the elderly – a review.
Osteoporos Int, (2013),
[13]
K.C. Roberts, W.T. Brox, D.S. Jevsevar, K. Sevarino.
Management of hip fractures in the elderly.
J Am Acad Orthop Surg, 23 (2015), pp. 131-137
[14]
T. Pareja-Sierra, I. Bartolomé-Martín, J. Rodríguez-Solís, L. Bárcena-Goitiandia, M. Torralba-Gónzalez de Suso, M.D. Morales-Sanz, et al.
Predictive factors of hospital stay, mortality and functional recovery after surgery for hip fracture in elderly patients.
Rev Esp Cir Ortop Traumatol, 61 (2017), pp. 427-435
[15]
International Osteoporosis Foundation. Capture the Fracture. International FLS Toolkit. Available from: https://www.osteoporosis.foundation/sites/iofbonehealth/files/2021-01/2014-IOF-CTF-FLS_toolkit_EN_WEB.pdf.
[16]
A. Nakayama, G. Major, E. Holliday, J. Attia, N. Bogduk.
Evidence of effectiveness of a fracture liaison service to reduce the re-fracture rate.
Osteoporos Int, 27 (2016), pp. 873-879
[17]
NICE. Hip fracture: management, Clinical guideline [CG124]. 2017.
[18]
S.D. Berry, L.A. Daiello, Y. Lee, A.R. Zullo, N.C. Wright, J.R. Curtis, et al.
Secular trends in the incidence of hip fracture among nursing home residents [published online ahead of print, 2020 Apr 17].
J Bone Miner Res, (2020),
[19]
J.E. Gjertsen, V. Baste, J.M. Fevang, O. Furnes, L.B. Engesaeter.
Quality of life following hip fractures: results from the Norwegian hip fracture register.
BMC Musculoskelet Disord, 17 (2016),
[20]
J.L. Conde-Sala, J. Garre-Olmo, L. Calvó-Perxas, O. Turró-Garriga, J. Vilalta-Franch, S. López-Pousa.
CAUSES, mortality rates and risk factors of death in community-dwelling Europeans aged 50 years and over: results from the Survey of Health, Ageing and Retirement in Europe 2013–2015 [published online ahead of print, 2020 Apr 3].
Arch Gerontol Geriatr, 89 (2020), pp. 104035
[21]
C.L. Hsu, H.M. Chen, H.J. Chen, M.Y. Chou, Y.C. Wang, Y.H. Hsu, et al.
A national study on long-term osteoporosis therapy and risk of recurrent fractures in patients with hip fracture.
Arch Gerontol Geriatr, 88 (2020), pp. 104021
[22]
Escribí, et al. En T. Pareja y J. Rodríguez, Guía de Ortogeriatría. Sociedad Castellano-Manchega de Geriatría y Gerontología, (pp. 170).
[23]
D. Marsh, K. Åkesson, D.E. Beaton, E.R. Bogoch, S. Boonen, M.L. Brandi, et al.
Coordinator-based systems for secondary prevention in fragility fracture patients.
Osteoporos Int, 22 (2011), pp. 2051-2065
[24]
M.J. Molina Hernández, C. González de Villaumbrosia, E. Martin de Francisco de Murga, T. Alarcón Alarcón, N. Montero- Fernández, J. Illán, et al.
Registro de fracturas de cadera multicéntrico de unidades de Ortogeriatria de la Comunidad Autónoma de Madrid.
Rev Esp Geriatr Gerontol, 54 (2019), pp. 5-11
[25]
Balvis-Balvis PM, Dominguez-Prado DM, Ferradás-García L, Pérez-García M, Garcia-Reza A, Castro-Menendez M. Influencia de la atención ortogeriátrica integrada en la morbimortalidad y el tiempo de estancia hospitalaria de la fractura de cadera, Revista Española de Cirugía Ortopédica y Traumatología, https://doi.org/10.1016/j.recot.2021.02.004.
[26]
J.I. González Montalvo, P. Gotor Pérez, A. Martín Vega, T. Alarcón Alarcón, J.L. Mauleón Álvarez de Liner, E. Gil Garay, et al.
La unidad de ortogeriatría de agudos Evaluación de su efecto en el curso clínico de los pacientes con fractura de cadera y estimación de su impacto económico.
Rev Esp Geriatr Gerontol, 46 (2011), pp. 193-199
[27]
D. González-Quevedo, D. Bautista-Enrique, V. Pérez-Del-Río, M. Bravo-Bardají, D. García-de-Quevedo, I. Tamimi.
Fracture liaison service and mortality in elderly hip fracture patients: a prospective cohort study.
Osteoporos Int, 31 (2020), pp. 77-84
[28]
D.J. Lee, J.C. Elfar.
Timing of hip fracture surgery in the elderly.
Geriatr Orthop Surg Rehabil, 5 (2014), pp. 138-140
[29]
M.K. Javaid, A. Sami, W. Lems, P. Mitchell, T. Thomas, A. Singer, et al.
A patient-level key performance indicator set to measure the effectiveness of fracture liaison services and guide quality improvement: a position paper of the IOF Capture the Fracture Working Group, National Osteoporosis Foundation and Fragility Fracture Network.
Osteoporos Int, 31 (2020), pp. 1193-1204

Please see a list of the members of the FLS-HPM team in Appendix A.

Copyright © 2022. SECOT
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos